What is CLYM's dilution risk score?

CLYM has a latest available DilutionScore record of 50/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CLYM, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CLYM?

DilutionWatch tracks 25 SEC filing types for CLYM including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CLYM shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CLYM, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CLYM tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CLYM. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CLYM Dilution Risk Score: 50/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

0

📊 Float Risk

65

⚠️ Warrant Exposure

90

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 30%

📜 Warrant Exercise model 60%

• Massive warrant overhang: 39% of shares outstanding

• Warrant risk score very high (90/100)

🔔 Track CLYM — Get forecast alerts →

Market Data

Market Cap$627.58M

Shares Outstanding57.44M

Float28.06M

Cash$183.12M

Debt$479.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 1.4% shares (2026Q1 vs prior)

83 institutional holders · 34.41M shares

#1 RA CAPITAL MANAGEMENT, L.P. 11.30M shares

#2 MPM BIOIMPACT LLC 2.59M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 2.36M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.04M

Days to Cover6.8

% of Float25.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31

8-K 8K EVENT 2026-04-28

4 INSIDER TRANSACTION 2026-02-27

4 INSIDER TRANSACTION 2026-02-17

4 INSIDER TRANSACTION 2026-01-08

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CLYM Dilution Snapshot

Climb Bio, Inc. (CLYM) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 22.5M.
Recent SEC activity tracked for CLYM: 8-K on 2026-04-28; 4 on 2026-02-27; 4 on 2026-02-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.